Successful treatment with intraluminal fibrinogen injection of serous leakage from a polytetrafluoroethylene Blalock-Taussig shunt

J Thorac Cardiovasc Surg. 2002 Nov;124(5):1037-8. doi: 10.1067/mtc.2002.124674.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Biocompatible Materials / adverse effects
  • Fibrinogen / therapeutic use*
  • Heart Bypass, Right / adverse effects*
  • Hemorrhage / etiology
  • Hemorrhage / therapy
  • Humans
  • Infant
  • Injections
  • Male
  • Pleural Effusion / etiology
  • Pleural Effusion / therapy
  • Polytetrafluoroethylene / adverse effects*
  • Postoperative Complications / etiology
  • Postoperative Complications / therapy
  • Tetralogy of Fallot / complications
  • Tetralogy of Fallot / therapy
  • Treatment Outcome

Substances

  • Biocompatible Materials
  • Fibrinogen
  • Polytetrafluoroethylene